For women, hormone replacement therapy has been re-evaluated
Without insurance, these medications can cost over $1,000 per month, making affordability a major factor when considering treatment
2017 Study: Glutathione = smoother skin, fewer wrinkles, improved elasticity
Earlier this month, (June 2025), Novo inked a deal worth up to $815 million with Deep Apple Therapeutics, a South San Francisco-based company specializing in small-molecule drug discovery to discover, develop, and commercialize oral small-molecule therapeutics directed at a non-incretin G protein-coupled receptors (GPCR) target for cardiometabolic diseases, including obesity, in a deal worth up to $812 million